Different health systems have different abilities to adopt health technologies. These differences may me even more apparent among countries with contrasting gross domestic products, state-based vs. private-based health systems, scientific and professional development levels, and population epidemiological profiles. Nonetheless, whenever new technology is determined to be cost-effective compared to previous available care, there may be significant individual and societal benefits to its adoption and access independent of health system.

The accurate determination of whether technologies are both clinically effective and cost-effective is thus of critical importance. The overall intent of most effectiveness measures is to provide an opportunity to improve the value of healthcare delivery by eliminating waste and possibly reducing costs where they are not justified. By merging data on clinical efficacy with cost to provide estimates of cost-effectiveness, health technology assessment (HTA) can be utilized to help generate evidence-based guidelines that support decision to utilize new technologies. The accurate evaluation of health technology requires an understanding of local disease epidemiology, institutional resources, specialized professional training, and clear political planning, surveillance, and evaluation instruments. read more...

Expected Outcomes

CUTEheart Icons-01

2 PhD thesis

CUTEheart Icons-02

6 papers

CUTEheart Icons-03

Several missions

CUTEheart Icons-04

2 workshops & 4 seminars


Principal Investigators




fmup logo  fmul logo  harvard logo